Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

2seventy bio Q4 EPS $(1.11) Misses $(0.99) Estimate, Sales $10.68M Miss $14.71M Estimate

Author: Benzinga Newsdesk | March 05, 2024 08:04am
2seventy bio (NASDAQ:TSVT) reported quarterly losses of $(1.11) per share which missed the analyst consensus estimate of $(0.99) by 12.12 percent. This is a 85 percent decrease over losses of $(0.60) per share from the same period last year. The company reported quarterly sales of $10.68 million which missed the analyst consensus estimate of $14.71 million by 27.37 percent. This is a 80.98 percent decrease over sales of $56.18 million the same period last year.

Posted In: TSVT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist